MD3692039T2 - Enantiomerii tiazolilor substituiți ca compuși antivirali - Google Patents

Enantiomerii tiazolilor substituiți ca compuși antivirali

Info

Publication number
MD3692039T2
MD3692039T2 MDE20200816T MDE20200816T MD3692039T2 MD 3692039 T2 MD3692039 T2 MD 3692039T2 MD E20200816 T MDE20200816 T MD E20200816T MD E20200816 T MDE20200816 T MD E20200816T MD 3692039 T2 MD3692039 T2 MD 3692039T2
Authority
MD
Moldova
Prior art keywords
enantiomers
antiviral compounds
substituted thiazoles
antiviral
drugs
Prior art date
Application number
MDE20200816T
Other languages
English (en)
Inventor
Gerald Kleymann
Christian Gege
Original Assignee
Innovative Molecules Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovative Molecules Gmbh filed Critical Innovative Molecules Gmbh
Publication of MD3692039T2 publication Critical patent/MD3692039T2/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms

Abstract

Invenţia de faţă se referă la compuşi noi antivirali cu stereoconfiguraţie specifică, în special la enantiomeri specifici noi, la un procedeu pentru prepararea acestora şi la utilizările lor ca medicamente, în particular ca medicamente antivirale.
MDE20200816T 2017-10-05 2018-10-04 Enantiomerii tiazolilor substituiți ca compuși antivirali MD3692039T2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17195047 2017-10-05
PCT/EP2018/077022 WO2019068817A1 (en) 2017-10-05 2018-10-04 SUBSTITUTED THIAZOLEAN ENANTIOMERS AS ANTIVIRAL COMPOUNDS

Publications (1)

Publication Number Publication Date
MD3692039T2 true MD3692039T2 (ro) 2023-05-31

Family

ID=60022026

Family Applications (1)

Application Number Title Priority Date Filing Date
MDE20200816T MD3692039T2 (ro) 2017-10-05 2018-10-04 Enantiomerii tiazolilor substituiți ca compuși antivirali

Country Status (36)

Country Link
US (2) US11278534B2 (ro)
EP (2) EP4209491A1 (ro)
JP (1) JP7215689B2 (ro)
KR (1) KR20200066619A (ro)
CN (1) CN111433203B (ro)
AR (1) AR113344A1 (ro)
AU (1) AU2018344471B2 (ro)
BR (1) BR112020006710A2 (ro)
CA (1) CA3077397A1 (ro)
CL (1) CL2020000869A1 (ro)
CR (1) CR20200154A (ro)
DK (1) DK3692039T3 (ro)
EA (1) EA202090620A1 (ro)
EC (1) ECSP20021132A (ro)
ES (1) ES2939652T3 (ro)
FI (1) FI3692039T3 (ro)
HR (1) HRP20230158T1 (ro)
HU (1) HUE061307T2 (ro)
IL (1) IL273681A (ro)
JO (1) JOP20200110A1 (ro)
LT (1) LT3692039T (ro)
MA (1) MA50609B1 (ro)
MD (1) MD3692039T2 (ro)
MX (1) MX2020003369A (ro)
NI (1) NI202000025A (ro)
PH (1) PH12020550132A1 (ro)
PL (1) PL3692039T3 (ro)
PT (1) PT3692039T (ro)
RS (1) RS64000B1 (ro)
SG (1) SG11202002420SA (ro)
SI (1) SI3692039T1 (ro)
TW (1) TWI706941B (ro)
UA (1) UA126163C2 (ro)
UY (1) UY37917A (ro)
WO (1) WO2019068817A1 (ro)
ZA (1) ZA202002150B (ro)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019068817A1 (en) * 2017-10-05 2019-04-11 Innovative Molecules Gmbh SUBSTITUTED THIAZOLEAN ENANTIOMERS AS ANTIVIRAL COMPOUNDS
US11760701B2 (en) 2018-02-27 2023-09-19 The Research Foundation For The State University Of New Yrok Difluoromethoxylation and trifluoromethoxylation compositions and methods for synthesizing same
TW202038947A (zh) 2018-11-28 2020-11-01 德商創新分子有限責任公司 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑
CN116783171A (zh) 2020-10-29 2023-09-19 创新分子股份有限公司 作为抗病毒化合物的氘化氨基噻唑化合物
TW202337444A (zh) 2022-01-17 2023-10-01 德商創新分子有限責任公司 解旋酶引子酶抑制劑的固體結晶形式及其製備方法
WO2024049760A1 (en) 2022-08-29 2024-03-07 Assembly Biosciences, Inc. Cyclic urea thiazolyl compounds for treatment of hsv
WO2024047508A1 (en) 2022-08-29 2024-03-07 Assembly Biosciences, Inc. Pharmaceutical compositions for herpes virus

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7100497A (ro) 1970-01-16 1971-07-20
NZ331104A (en) 1995-12-29 2000-03-27 Boehringer Ingelheim Ca Ltd Phenyl thiazole derivatives that inhibit herpes replication by inhibiting the herpes helicase primase enzyme complex
US6040321A (en) * 1997-11-12 2000-03-21 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
AU3289299A (en) 1998-02-19 1999-09-06 Tularik Inc. Antiviral agents
JP2002506858A (ja) 1998-03-19 2002-03-05 ファルマシア・アンド・アップジョン・カンパニー Ｃｍｖ感染症の治療に有用な１，３，４−チアジアゾール
WO2000053591A1 (de) 1999-03-08 2000-09-14 Bayer Aktiengesellschaft Thiazolylharnstoff-derivate und ihre verwendung als antivirale mittel
DE19959958A1 (de) 1999-12-13 2001-08-30 Bayer Ag Thiazolylharnstoff-Derivate
DE19927415A1 (de) 1999-06-16 2000-12-21 Bayer Ag Indolinylharnstoffderivate
DOP2000000109A (es) 1999-12-23 2002-08-30 Gerald Kleymann Derivados de tiazolilamida
DE10039265A1 (de) 2000-08-11 2002-02-21 Bayer Ag Thiazolylamid-Derivate
WO2001096874A1 (en) 2000-06-15 2001-12-20 Bayer Aktiengesellschaft Method for identifying compounds with anti-herpes activity
DE10038022A1 (de) 2000-08-04 2002-02-14 Bayer Ag Inverse Thiazolylamid-Derivate
DE10044328A1 (de) 2000-09-07 2002-03-21 Bayer Ag Thiazolylcarbonyl-Derivate
DE10044353A1 (de) 2000-09-07 2002-04-04 Bayer Ag Unkompetitive Inhibitoren der Helikase-Primase
DE10044358A1 (de) 2000-09-07 2002-03-21 Bayer Ag Thiazolylcarbonylheterocyclyl-Derivate
DE10129714A1 (de) 2001-06-22 2003-01-02 Bayer Ag Topische Anwendung von Thiazolylamiden
DE10129715A1 (de) 2001-06-22 2003-01-02 Bayer Ag Thiazolylamide
DE10129716A1 (de) 2001-06-22 2003-01-02 Bayer Ag Kombinationspräparate zur Herpes-Behandlung
DE10129717A1 (de) 2001-06-22 2003-01-02 Bayer Ag Kombinationspräparate zur Herpes-Behandlung
DE10131128A1 (de) 2001-06-28 2003-01-16 Bayer Ag Sekundäre Sulfonamide
DE10210319A1 (de) 2002-03-08 2003-09-18 Bayer Ag Thiazolylcarbonyl-Derivate
DE10235967B4 (de) 2002-08-06 2005-09-08 Bayer Healthcare Ag Methode zum Identifizieren von Substanzen mit antimikrobieller Wirkung
DE10300109A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Methode zur Inhibition der Replikation von Herpesviren
AU2005210474B2 (en) 2004-01-30 2011-07-07 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding cassette transporters
DE102005014248A1 (de) 2005-03-30 2006-10-05 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid
US8548554B2 (en) 2006-12-08 2013-10-01 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Dry electrode cap for electro-encephalography
DE102010046720A1 (de) 2010-09-23 2012-03-29 Bayer Schering Pharma Aktiengesellschaft Verfahren zur Herstellung von pan-CDK-Inhibitoren der Formel (l), sowie Intermediate der Herstellung
AU2011323682B2 (en) * 2010-11-01 2016-06-23 Romark Laboratories L.C. Alkylsulfinyl-substituted thiazolide compounds
TW201636330A (zh) 2011-05-24 2016-10-16 拜耳知識產權公司 含有硫醯亞胺基團之４－芳基－ｎ－苯基－１，３，５－三氮雜苯－２－胺
EP2573086A1 (en) 2011-09-26 2013-03-27 AiCuris GmbH & Co. KG N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate
TWI706940B (zh) * 2016-04-06 2020-10-11 德商創新分子有限責任公司 新穎之抗病毒化合物
AR110251A1 (es) 2016-11-28 2019-03-13 Aicuris Anti Infective Cures Gmbh Una sal maleato de la base libre de n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida, formulaciones farmacéuticas, métodos de fabricación y usos de la misma
US11021474B2 (en) 2016-11-28 2021-06-01 Aicuris Anti-Infective Cures Gmbh N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof
WO2018095576A1 (en) 2016-11-28 2018-05-31 Aicuris Anti-Infective Cures Gmbh Topical pharmaceutical formulation comprising n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide
WO2018127207A1 (zh) 2017-01-09 2018-07-12 南京明德新药研发股份有限公司 噻唑衍生物及其应用
WO2019068817A1 (en) * 2017-10-05 2019-04-11 Innovative Molecules Gmbh SUBSTITUTED THIAZOLEAN ENANTIOMERS AS ANTIVIRAL COMPOUNDS

Also Published As

Publication number Publication date
AR113344A1 (es) 2020-04-22
MX2020003369A (es) 2020-07-29
RS64000B1 (sr) 2023-03-31
ZA202002150B (en) 2022-10-26
EP4209491A1 (en) 2023-07-12
HUE061307T2 (hu) 2023-06-28
CL2020000869A1 (es) 2020-09-21
SI3692039T1 (sl) 2023-04-28
ES2939652T3 (es) 2023-04-25
TW201927758A (zh) 2019-07-16
US11278534B2 (en) 2022-03-22
EP3692039B1 (en) 2022-12-14
AU2018344471B2 (en) 2022-09-29
UY37917A (es) 2019-04-30
CN111433203A (zh) 2020-07-17
MA50609A (fr) 2020-08-12
PL3692039T3 (pl) 2023-04-17
NI202000025A (es) 2020-07-31
WO2019068817A1 (en) 2019-04-11
PH12020550132A1 (en) 2021-02-08
JOP20200110A1 (ar) 2020-05-07
BR112020006710A2 (pt) 2022-11-08
EP3692039A1 (en) 2020-08-12
ECSP20021132A (es) 2020-07-31
LT3692039T (lt) 2023-03-27
FI3692039T3 (fi) 2023-03-23
CR20200154A (es) 2020-05-24
MA50609B1 (fr) 2023-03-31
PT3692039T (pt) 2023-03-07
US20220152008A1 (en) 2022-05-19
US20200289486A1 (en) 2020-09-17
AU2018344471A1 (en) 2020-04-09
UA126163C2 (uk) 2022-08-25
HRP20230158T1 (hr) 2023-03-31
SG11202002420SA (en) 2020-04-29
EA202090620A1 (ru) 2020-07-10
DK3692039T3 (da) 2023-03-13
CA3077397A1 (en) 2019-04-11
TWI706941B (zh) 2020-10-11
JP2020536108A (ja) 2020-12-10
KR20200066619A (ko) 2020-06-10
CN111433203B (zh) 2024-02-13
JP7215689B2 (ja) 2023-01-31
IL273681A (en) 2020-05-31

Similar Documents

Publication Publication Date Title
MD3692039T2 (ro) Enantiomerii tiazolilor substituiți ca compuși antivirali
CL2017001930A1 (es) Derivados de 4h-pirrol[3,2-c]piridin-4-ona
EA201890126A1 (ru) Новые бициклические производные, способ их получения и фармацевтические композиции, содержащие их
EA201692193A1 (ru) Способы получения ингибитора jak1 и его новых форм
EA201692414A1 (ru) (2R,5S,13aR)-7,9-ДИОКСО-10-((2,4,6-ТРИФТОРБЕНЗИЛ)КАРБАМОИЛ)-2,3,4,5,7,9,13,13a-ОКТАГИДРО-2,5-МЕТАНОПИРИДО[1',2':4,5]ПИРАЗИНО[2,1-b][1,3]ОКСАЗЕПИН-8-ОЛАТ НАТРИЯ
AU2015208932A8 (en) (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase I inhibitors
CR20160503A (es) Compuestos de [1,2,4] triazol e imidazol sustituidos, como fungicidas
EA201692219A1 (ru) Способы получения противовирусных соединений
ECSP18074962A (es) Derivados de aminotiazol útiles como agentes antivíricos
CL2016002207A1 (es) Compuestos derivados de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona, con actividad antibacteriana gram (+) y gram (-); composicion farmacéutica que los comprende.
MX2017016619A (es) Derivados de pirimidina como inhibidores de tirosina cinasa de bruton (btk) y usos de los mismos.
MX2016009794A (es) Derivado de sulfonamida heterociclico y medicina que comprende el mismo.
EA201790939A1 (ru) ТРИАЗОЛО[4,5-d]ПИРИМИДИНЫ В КАЧЕСТВЕ АГОНИСТОВ КАННАБИНОИДНЫХ РЕЦЕПТОРОВ ТИПА 2
EA201691982A1 (ru) 5,6-дизамещенные пиридин-2-карбоксамиды в качестве агонистов каннабиноидных рецепторов
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
EA201790982A1 (ru) Синтез копанлисиба и его дигидрохлорида
EA201890632A1 (ru) Хиральные фосфорамидимидаты и их производные
MD3395821T2 (ro) Compuși antitumorali
MX2018004979A (es) Compuesto piranodipiridinico.
IN2014MU00455A (ro)
BR112016022437A2 (pt) Processo para preparação de (2s,5r)-6-(benziloxi)-7-oxo-1,6- diazabiciclo[3,2,1]octano-2-carboxilato de sódio
PH12017501869A1 (en) (s)-2'-vinyl-abscisic acid derivatives
PH12016502592A1 (en) 3'-substituted-abscisic acid derivatives
GB2564185A (en) Process for the preparation of derivatives of benzodioxole
WO2015001568A3 (en) Sitagliptin lipoate salt, process for the preparation and pharmaceutical composition thereof